Table 4.

Hazard ratios of hospitalization for heart failure in patients post mitral valve (MV) repair for degenerative mitral regurgitation.

Variables	HR	p
Male	2.1 (0.24–19.2)	0.49
Hypertension	3.1 (0.6–16.3)	0.16
ERO (baseline)	0.11 (0.002–8.41)	0.32
ERO change	21.02 (0.45–98.1)	0.12
RVol (baseline)	0.98 (0.95–1.01)	0.27
RVol change	1.04 (0.92–1.17)	0.47
LVEF (baseline)	1.01 (0.82–1.27)	0.72
LV GLS (baseline)	1.06 (0.94–1.19)	0.31
LAVi (baseline)	0.99 (0.98–1.01)	0.89
FAC (baseline)	1.03 (0.97–1.09)	0.22
TAPSE (baseline)	1.25 (0.74–1.39)	0.62
TAPSE (post 6M)	1.05 (0.93–1.19)	0.08
TAPSE changes	1.12 (0.82–1.45)	0.23
S′	1.02 (0.79–1.31)	0.85
RV strain (baseline)	0.95 (0.86–1.05)	0.34
RV strain (post 1 month)	1.33 (1.07–1.66)	0.009
RV reserve	12.8 (3.5–28.9)	0.001

Abbreviation as Table 2.